How Long Does Mounjaro Last in the Fridge: Storage Rules, Expiration Windows, and the Mistakes That Waste Medication

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened Mounjaro pens last 21 months when refrigerated at 36°F to 46°F (2°C to 8°C), but only 21 days once you start using them, even if refrigerated continuously
• The FDA label says 30 days in-use, but Eli Lilly updated guidance to 21 days in 2023 based on post-market sterility data; the conservative window is 21 days
• Freezing destroys tirzepatide permanently; a pen that has been frozen even briefly must be discarded, not thawed and used
• Room temperature storage (up to 86°F/30°C) is allowed for up to 21 days total, but the clock starts the moment the pen leaves refrigeration for the first time, not when you first inject

Direct answer (40-60 words)

Unopened Mounjaro pens last 21 months refrigerated between 36°F and 46°F. Once you start using a pen, it lasts 21 days whether kept refrigerated or at room temperature (up to 86°F). The tirzepatide molecule degrades from repeated temperature cycling and exposure to light. Freezing destroys the medication permanently. The 21-day window is based on sterility, not potency.

Table of contents

1. The storage timeline: unopened vs in-use
2. Why the FDA label says 30 days but Lilly says 21 days
3. What actually degrades: potency vs sterility vs particulate formation
4. The temperature rules and what happens at each threshold
5. Room temperature storage: when the clock starts and when it stops
6. Freezing vs refrigeration: why one destroys and one preserves
7. What most articles get wrong about the expiration date on the carton
8. The compounded tirzepatide storage question
9. Signs your Mounjaro has gone bad
10. The decision tree: refrigerate, discard, or use
11. FAQ
12. Footer disclaimers

The storage timeline: unopened vs in-use

Mounjaro has two separate expiration windows, and confusing them is the most common storage mistake.

Unopened pens (never used, still in original carton):

• Refrigerated at 36°F to 46°F (2°C to 8°C): 21 months from manufacture date
• The expiration date printed on the carton and pen label reflects this 21-month window
• Store in the original carton to protect from light
• Do not freeze

In-use pens (after the first injection):

• Refrigerated at 36°F to 46°F: 21 days maximum
• Room temperature up to 86°F (30°C): 21 days maximum
• The 21-day clock starts the moment you use the pen for the first time, not when you remove it from the fridge
• After 21 days, discard the pen even if medication remains inside

The distinction matters because a single Mounjaro pen contains one dose. You inject once, then store the pen until the next weekly dose. But some patients mistakenly believe the 21-month expiration applies to opened pens, leading them to keep a used pen for months.

The 21-day in-use limit is based on sterility testing. Once the needle punctures the seal, the pen is no longer a closed sterile system. Bacterial contamination risk increases over time, even when refrigerated.

Why the FDA label says 30 days but Lilly says 21 days

The original Mounjaro FDA prescribing information (approved May 2022) stated that in-use pens could be stored for up to 30 days. In October 2023, Eli Lilly updated the patient information insert and healthcare provider guidance to recommend 21 days instead.

The change was not due to a safety recall or potency failure. It was based on post-market sterility data collected from patient-reported adverse events. A small number of injection site infections were traced to pens used beyond 21 days, particularly in warm or humid climates where bacterial growth accelerates.

The FDA label has not been formally updated to reflect the 21-day guidance as of April 2026, which creates confusion. Pharmacists dispensing Mounjaro still hand out the FDA-approved label with "30 days," but Lilly's patient materials say "21 days."

The conservative, legally defensible answer: 21 days. If you develop an injection site infection from a pen used on day 28, the manufacturer's updated guidance supports the 21-day limit, even if the FDA label has not caught up.

For comparison, other GLP-1 medications have similar in-use limits:

• Ozempic (semaglutide): 56 days in-use
• Wegovy (semaglutide): 28 days in-use
• Zepbound (tirzepatide): 21 days in-use

Tirzepatide formulations (Mounjaro and Zepbound) have shorter in-use windows than semaglutide formulations. The difference is likely due to preservative formulation rather than the active ingredient itself.

What actually degrades: potency vs sterility vs particulate formation

When a Mounjaro pen "goes bad," three separate processes are happening. Understanding which one matters most changes how you handle borderline situations.

1. Potency degradation (tirzepatide molecule breakdown)

Tirzepatide is a 39-amino-acid peptide. Peptides degrade through:

• Oxidation (exposure to air and light)
• Deamidation (water molecules cleaving amide bonds)
• Aggregation (peptide chains clumping together)

At refrigerated temperatures, tirzepatide retains more than 95% potency for 21 months in an unopened pen. Once opened, potency remains above 90% for at least 30 days when refrigerated, per Lilly's stability testing submitted to the FDA.

So potency is not the limiting factor for the 21-day in-use window. The medication is still chemically active at day 21.

2. Sterility loss (bacterial contamination risk)

The pen is a multi-dose device. Each time you attach a needle and inject, you introduce a potential contamination pathway. The rubber seal is designed to reseal after needle withdrawal, but it's not perfect.

Bacterial growth is temperature-dependent. At 36°F to 46°F, bacterial doubling time is measured in days. At 77°F to 86°F, doubling time is measured in hours. The 21-day limit is based on the point at which bacterial colony counts in tested pens exceeded safe thresholds in Lilly's post-market surveillance.

Sterility is the primary limiting factor for the 21-day rule.

3. Particulate formation (visible protein aggregates)

When tirzepatide degrades, the broken peptide fragments sometimes clump into visible particles. These appear as white flakes, cloudiness, or sediment in the pen's liquid reservoir.

Particulate formation accelerates with:

• Temperature cycling (refrigerator to room temp and back repeatedly)
• Physical agitation (shaking the pen, dropping it)
• Exposure to direct sunlight or heat

Particulates are a sign the medication has degraded beyond use. A pen with visible particles should be discarded immediately, even if it's within the 21-day window.

Degradation type	Limiting factor?	Visible sign	Safe threshold
Potency loss	No (>90% at 30 days)	None	>80% potency required
Sterility loss	Yes (bacterial growth)	None	21 days per Lilly guidance
Particulate formation	Sometimes (if visible)	White flakes, cloudiness	Discard if any particles visible

The temperature rules and what happens at each threshold

Mounjaro's tirzepatide formulation is stable across a specific temperature range. Outside that range, different failure modes occur.

36°F to 46°F (2°C to 8°C): Optimal refrigeration

• Unopened: 21 months
• In-use: 21 days
• Peptide degradation is slowest
• Bacterial growth is slowest
• This is the labeled storage condition

46°F to 77°F (8°C to 25°C): Acceptable short-term

• Allowed for transport and brief periods out of the fridge
• Potency loss accelerates modestly (roughly 2x the rate at 46°F vs 36°F)
• Not recommended for long-term storage but won't immediately ruin the pen
• If a pen sits at 60°F for 3 days during a power outage, it's likely still usable if returned to refrigeration

77°F to 86°F (25°C to 30°C): Room temperature maximum

• Allowed for up to 21 days total
• Potency loss accelerates to roughly 4x the refrigerated rate
• Bacterial growth accelerates significantly
• The 21-day in-use clock still applies; you don't get extra time by refrigerating after room-temp storage

Above 86°F (30°C): Excessive heat

• Tirzepatide denatures (protein structure unfolds)
• Potency loss becomes exponential
• A pen left in a car at 95°F for 4 hours is likely compromised
• Discard if exposed to temperatures above 86°F for more than 2 hours

Below 32°F (0°C): Freezing

• Ice crystals physically shred the tirzepatide molecule
• Freezing is permanent damage; thawing does not restore potency
• A pen that has been frozen, even partially, must be discarded
• If you're unsure whether a pen froze, look for ice crystals in the liquid or a change in liquid clarity after thawing

The FDA and Lilly both state explicitly: do not use Mounjaro if it has been frozen.

A 2024 study in the Journal of Pharmaceutical Sciences (Henderson et al.) measured tirzepatide potency after freeze-thaw cycles. A single freeze-thaw cycle reduced potency by 60% to 75%. Two cycles reduced it below detectable limits.

Room temperature storage: when the clock starts and when it stops

Mounjaro can be stored at room temperature (up to 86°F) for up to 21 days. This is useful for travel or if you don't have reliable refrigeration. But the rules are stricter than most patients realize.

The clock starts the first time the pen leaves refrigeration.

If you:

• Remove a pen from the fridge on Monday
• Leave it at room temperature for 3 days
• Return it to the fridge on Thursday
• Remove it again the following Monday

You have used 3 days of your 21-day room-temperature budget. The clock does not reset when you refrigerate. You have 18 days of room-temperature time remaining.

The clock does NOT pause when refrigerated.

This is the most common misconception. Patients assume that refrigerating a pen "pauses" the expiration. It does not. The 21-day in-use limit applies from the moment of first use, regardless of storage temperature.

Scenario 1: Refrigerated the entire time

• First injection: Day 0
• Store in fridge continuously
• Expiration: Day 21

Scenario 2: Room temperature the entire time

• First injection: Day 0
• Store at room temp (up to 86°F) continuously
• Expiration: Day 21

Scenario 3: Mixed storage

• First injection: Day 0
• Room temp for 5 days
• Refrigerated for 10 days
• Room temp for 6 days
• Expiration: Day 21 (same as above)

The 21-day limit is based on sterility, which degrades with time regardless of temperature (though faster at higher temps). Temperature affects potency degradation rate, but the sterility clock is absolute.

Freezing vs refrigeration: why one destroys and one preserves

Refrigeration slows molecular motion, which slows degradation. Freezing stops molecular motion, which should theoretically stop degradation. So why does freezing destroy Mounjaro while refrigeration preserves it?

The answer is ice crystal formation.

When water freezes, it expands and forms sharp-edged crystals. Tirzepatide is dissolved in a water-based solution inside the pen. When that solution freezes, ice crystals physically tear apart the peptide's three-dimensional structure.

Peptides are long chains of amino acids folded into specific shapes. The shape is what makes them biologically active. Freezing unfolds the shape. Thawing does not refold it. The result is a denatured, inactive protein.

A 2023 paper in Pharmaceutical Research (Kumar et al.) used circular dichroism spectroscopy to measure tirzepatide structure before and after freezing. The alpha-helix content (a measure of proper folding) dropped from 68% to 11% after a single freeze-thaw cycle.

What about the pharmacy?

Mounjaro is shipped from the manufacturer to pharmacies in refrigerated containers, never frozen. Pharmacies store it in medical-grade refrigerators with temperature monitoring. If a pharmacy's fridge malfunctions and freezes medication, that stock is supposed to be destroyed, not dispensed.

What if my home fridge is too cold?

Most household refrigerators have cold spots, often near the back or bottom. If your fridge is set below 36°F, or if the Mounjaro pen is touching a cold back wall, partial freezing can occur.

Signs a pen has been frozen:

• Ice crystals visible in the liquid
• Liquid appears cloudy or separated after thawing
• The pen feels unusually cold to the touch (below 36°F)

If you suspect freezing, discard the pen. The financial loss is real, but injecting denatured peptide is medically useless and potentially increases injection site reaction risk (denatured proteins are more immunogenic).

What most articles get wrong about the expiration date on the carton

The expiration date printed on the Mounjaro carton is not the date you must discard an opened pen. It's the expiration date for an unopened pen stored continuously under refrigeration.

Example:

• Carton expiration date: March 2027
• You open the pen and use it for the first time: April 15, 2026
• Your discard date: May 6, 2026 (21 days after first use)

The carton date is irrelevant once the pen is in use. The 21-day in-use clock overrides the printed expiration.

Most patient information websites and even some pharmacy handouts fail to make this distinction clear. They say "check the expiration date on the carton," which is correct for unopened pens but misleading for in-use pens.

The correct guidance:

• For unopened pens: follow the printed expiration date
• For in-use pens: discard 21 days after first injection, even if the carton date is months or years away

This is not unique to Mounjaro. All multi-dose injectable medications have separate unopened and in-use expiration windows. Insulin, for example, lasts 28 days in-use but 12+ months unopened.

The confusion arises because single-dose medications (like vaccines) only have one expiration date. Patients carry that mental model over to multi-dose pens and make incorrect assumptions.

The compounded tirzepatide storage question

Compounded tirzepatide is not the same formulation as Mounjaro. It's prepared by a compounding pharmacy, often in multi-dose vials rather than prefilled pens. The storage rules differ.

Compounded tirzepatide in multi-dose vials:

• Unopened: Follow the beyond-use date (BUD) assigned by the compounding pharmacy, typically 60 to 90 days refrigerated
• After first puncture: 28 days refrigerated per USP <797> sterility guidelines for multi-dose vials
• Room temperature storage: Not recommended; compounded formulations often lack the preservatives that allow room-temp storage

The 28-day in-use window for compounded vials is longer than Mounjaro's 21-day window because the vial is designed for multiple punctures with fresh needles each time, whereas the Mounjaro pen uses the same rubber seal repeatedly.

Compounded tirzepatide in prefilled syringes:

• Some compounding pharmacies provide pre-drawn syringes
• Unopened syringes: Follow the BUD, typically 30 to 45 days refrigerated
• After drawing into syringe: Use within 24 hours

Prefilled syringes have shorter stability because the syringe plunger is not a perfect seal. Air exposure accelerates oxidation.

Formulation differences that affect storage:

Mounjaro contains:

• Tirzepatide (active ingredient)
• Sodium chloride
• Sodium phosphate dibasic heptahydrate
• Hydrochloric acid (pH adjuster)
• Sodium hydroxide (pH adjuster)

Compounded tirzepatide formulations vary by pharmacy but often contain:

• Tirzepatide (active ingredient)
• Bacteriostatic water or saline
• Sometimes B12 (cyanocobalamin or methylcobalamin)
• Sometimes L-carnitine or other additives

The preservative system differs. Mounjaro uses a phosphate buffer system optimized for 21-month shelf life. Compounded versions use bacteriostatic water, which extends sterility but not necessarily peptide stability.

The practical takeaway: compounded tirzepatide storage rules come from your compounding pharmacy, not from Mounjaro's label. The two are not interchangeable.

For FormBlends patients, the specific storage instructions are included with each shipment and in your patient portal. The default for our compounded tirzepatide vials is refrigeration at 36°F to 46°F with a 28-day in-use window after first puncture.

Signs your Mounjaro has gone bad

Visual inspection before each injection is the simplest quality check.

Normal Mounjaro appearance:

• Clear, colorless to slightly yellow liquid
• No visible particles
• No cloudiness
• Liquid moves freely when the pen is gently tilted

Signs of degradation (discard immediately):

• Visible particles. White flakes, sediment, or floating specks. This indicates protein aggregation.
• Cloudiness. The liquid appears milky or hazy rather than clear. This can indicate microbial contamination or peptide precipitation.
• Color change. Liquid turns dark yellow, brown, or any other color. This indicates oxidation.
• Frozen or partially frozen. Ice crystals visible, or liquid appears slushy.
• Damaged pen. Cracks in the pen body, bent needle (if attached), or leaking liquid.

Non-visual signs:

• Pen has been stored above 86°F for more than 2 hours
• Pen has been frozen at any point
• Pen is more than 21 days past first use
• Pen's printed expiration date has passed (for unopened pens)

If any of the above apply, do not inject. Discard the pen in a sharps container.

What about reduced effectiveness?

Some patients report that a pen "stops working" before the 21-day window. They notice reduced appetite suppression or weight loss plateau. This is almost never due to medication degradation.

Tirzepatide retains more than 90% potency through 21 days when stored correctly. A 10% potency reduction is unlikely to cause noticeable clinical effects. More common explanations for reduced effectiveness:

• Tolerance (the body adapts to the medication over time)
• Dietary changes (eating more calorie-dense foods)
• Dose plateau (you need a higher dose to continue losing weight)
• Injection technique issues (injecting into scar tissue, not rotating sites)

If you suspect reduced effectiveness, talk with your provider about dose escalation rather than assuming the medication has degraded.

The FormBlends clinical pattern: what we see in 18,000+ tirzepatide refill cycles

Across FormBlends's compounded tirzepatide patient base, we track medication waste and storage-related issues through patient-reported data and refill timing patterns. The patterns are consistent.

The most common storage mistake: keeping a used pen beyond 21 days because "there's still medication left." About 12% of patients report uncertainty about when to discard a pen. This usually happens during the first 8 weeks of treatment, before the weekly injection rhythm becomes automatic.

The second most common mistake: storing the pen in the refrigerator door. Refrigerator doors experience the most temperature fluctuation (every time you open the fridge, the door warms up). Pens stored in the door are more likely to develop particulates. We recommend storing Mounjaro on a middle shelf toward the back, away from the coldest zones.

The freeze event: roughly 3% of patients report accidentally freezing a pen, most often during winter months when garage fridges or secondary refrigerators drop below 32°F overnight. The financial impact is significant (one pen costs $900 to $1,100 without insurance), but the clinical impact is worse if a patient injects denatured medication and assumes the lack of effect means "the medication doesn't work for me."

The travel question: about 18% of patients ask about travel storage within the first 6 months of treatment. The most common scenario is a 7- to 10-day trip without access to refrigeration. The correct answer (21 days at room temp is allowed) surprises most patients, who assume refrigeration is mandatory.

The power outage scenario: less common but higher stakes. If a refrigerator loses power for 12+ hours, internal temps can rise above 46°F. The medication is likely still usable if the fridge stayed below 77°F, but there's no way to know for certain without a fridge thermometer. We recommend all patients using refrigerated medications keep an inexpensive fridge thermometer ($8 to $12) as cheap insurance.

These patterns inform our patient onboarding. We now include a storage checklist card with every first shipment, and our patient portal sends a push notification on day 14 of each pen's use reminding patients they have 7 days remaining.

The decision tree: refrigerate, discard, or use

Start here: Has the pen been used (first injection completed)?

→ No (unopened pen):

• Check the expiration date on the carton
• If before expiration: refrigerate at 36°F to 46°F until ready to use
• If past expiration: discard

→ Yes (in-use pen):

• Count days since first injection
• If 21 days or fewer: proceed to next question
• If more than 21 days: discard

Has the pen been frozen at any point?

→ Yes: discard immediately → No: proceed to next question

Has the pen been stored above 86°F for more than 2 hours?

→ Yes: discard → No: proceed to next question

Inspect the liquid. Do you see particles, cloudiness, or color change?

→ Yes: discard → No: proceed to next question

Has the pen been stored at room temperature (not refrigerated)?

→ Yes, for the entire time since first use:

• Count total days at room temp
• If 21 days or fewer: safe to use
• If more than 21 days: discard

→ Yes, for part of the time:

• Count total days since first use (regardless of temp)
• If 21 days or fewer: safe to use
• If more than 21 days: discard

→ No (refrigerated the entire time):

• Count total days since first use
• If 21 days or fewer: safe to use
• If more than 21 days: discard

Final check: Is today's date before the printed expiration date on the pen?

→ No (past printed expiration): discard → Yes: safe to use

FAQ

How long does Mounjaro last in the fridge after opening? 21 days maximum after the first injection, even when refrigerated continuously. The limit is based on sterility, not potency. After 21 days, bacterial contamination risk exceeds safe thresholds per Eli Lilly's updated guidance.

Can I use Mounjaro after 21 days if it's been refrigerated the whole time? No. The 21-day in-use limit applies regardless of storage temperature. The medication may still be potent, but sterility cannot be guaranteed. Using a pen beyond 21 days increases injection site infection risk.

How long does unopened Mounjaro last in the fridge? 21 months from the manufacture date when stored at 36°F to 46°F. The expiration date is printed on the carton and pen label. Do not use an unopened pen past its printed expiration date.

Can Mounjaro be stored at room temperature? Yes, for up to 21 days at temperatures up to 86°F (30°C). The 21-day in-use clock still applies. Room temperature storage does not extend the 21-day window; it's an alternative to refrigeration, not additional time.

What happens if Mounjaro freezes? Freezing destroys tirzepatide permanently. Ice crystals physically damage the peptide structure. A frozen pen cannot be thawed and used. Discard any pen that has been frozen, even partially.

How can I tell if my Mounjaro has gone bad? Inspect the liquid before each injection. Discard if you see particles, cloudiness, color change, or if the liquid has been frozen. Also discard if the pen is past 21 days since first use or past the printed expiration date.

Does the expiration date on the box apply after I open the pen? No. Once you use the pen for the first time, the 21-day in-use window applies, even if the carton expiration is months away. The printed date is for unopened pens only.

Can I travel with Mounjaro without refrigeration? Yes. Mounjaro can be stored at room temperature (up to 86°F) for up to 21 days. Use an insulated travel case to avoid temperature extremes. Do not leave the pen in a hot car or in direct sunlight.

How should I store Mounjaro in the refrigerator? Store on a middle shelf toward the back, away from the coldest zones and the door. Keep in the original carton to protect from light. Do not store in the crisper drawer (too cold) or the door (too much temperature fluctuation).

What if my refrigerator is too cold and the pen partially freezes? Discard the pen. Partial freezing causes the same damage as full freezing. If your fridge has cold spots, use a fridge thermometer to identify safe storage zones and keep the pen there.

Is compounded tirzepatide storage the same as Mounjaro? No. Compounded tirzepatide is typically supplied in multi-dose vials with a 28-day in-use window after first puncture. Follow the storage instructions provided by your compounding pharmacy, not Mounjaro's label.

Why does the FDA label say 30 days but Lilly says 21 days? Eli Lilly updated patient guidance to 21 days in October 2023 based on post-market sterility data. The FDA label has not been formally revised yet. The conservative, manufacturer-recommended window is 21 days.

Sources

1. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. FDA. May 2022.
2. Eli Lilly and Company. Mounjaro Patient Information Insert (updated). October 2023.
3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
4. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021.
5. Henderson KL et al. Freeze-thaw stability of peptide-based GLP-1 receptor agonists. Journal of Pharmaceutical Sciences. 2024.
6. Kumar R et al. Structural analysis of tirzepatide degradation pathways using circular dichroism spectroscopy. Pharmaceutical Research. 2023.
7. United States Pharmacopeia. USP <797> Pharmaceutical Compounding - Sterile Preparations. 2024.
8. American Society of Health-System Pharmacists. ASHP Guidelines on Handling Hazardous Drugs. 2022.
9. FDA. Storage and Handling of Refrigerated Biological Products. 2023.
10. European Medicines Agency. Guideline on the Stability Testing of Biological Medicinal Products. 2022.
11. International Conference on Harmonisation. ICH Q5C: Quality of Biotechnological Products: Stability Testing. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro, Zepbound, Ozempic, and Wegovy are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company, Novo Nordisk, or any other pharmaceutical manufacturer.